# A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

> **NCT02892812** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 63 (actual)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** Pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT02892812
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892812, "A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02892812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*